Muhammad Takhman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Takhman has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Reem Shihab
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine, najah.edu
5 shared publications - Moath Hattab
Department of Medicine, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, Palestine
4 shared publications - Mohammad Bdair
Department of Medicine, Faculty of Medicine and Health Sciences An‐Najah National University Nablus Palestine
2 shared publications - Sultan Mosleh
Department of Medicine, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, Palestine
2 shared publications Adam A. Dmytriw
Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA; Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada
1 shared publicationAhmed Msherghi
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
1 shared publication
Latest Publications
- 8 April 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 267, 109429
Cerebrovascular outcomes in reversible cerebral vasoconstriction syndrome with and without posterior reversible encephalopathy syndrome
- 8 April 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 267, 109429
Cerebrovascular outcomes in reversible cerebral vasoconstriction syndrome with and without posterior reversible encephalopathy syndrome
- Open Access
- 22 January 2026
- Published by Springer Nature in Research Square
Extrarenal Staghorn Stone Migration, a Rare Complication of Percutaneous Nephrolithotomy
Staghorn stones are large branched structures that occupy the renal collecting system, and are usually treated with percutaneous nephrolithotomy (PCNL), this treatment is rarely complicated by extrarenal stone migration, we highlight the diagnostic difficulty in a 36-year-old male that developed extrarenal stone migration and went undiagnosed for 9 months post-PCNL, CT imaging revealed fragments outside the renal collecting system, leading to hydroureteronephrosis and requiring multiple ureteroscopic interventions. We highlight the limitation of x-rays in detecting such complications and emphasize the importance of CT imaging for accurate diagnosis and management, and the role of standardized guidelines in such cases
- 22 January 2026
- Published by Springer Nature in Research Square
Open AccessExtrarenal Staghorn Stone Migration, a Rare Complication of Percutaneous Nephrolithotomy
Staghorn stones are large branched structures that occupy the renal collecting system, and are usually treated with percutaneous nephrolithotomy (PCNL), this treatment is rarely complicated by extrarenal stone migration, we highlight the diagnostic difficulty in a 36-year-old male that developed extrarenal stone migration and went undiagnosed for 9 months post-PCNL, CT imaging revealed fragments outside the renal collecting system, leading to hydroureteronephrosis and requiring multiple ureteroscopic interventions. We highlight the limitation of x-rays in detecting such complications and emphasize the importance of CT imaging for accurate diagnosis and management, and the role of standardized guidelines in such cases
- Open Access
- 11 December 2025
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Salbutamol in Congenital Myasthenic Syndrome: A Systematic Review
Congenital myasthenic syndromes (CMS) are inherited disorders of neuromuscular transmission with few effective treatments. Salbutamol, a β2-adrenergic
- 11 December 2025
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessSalbutamol in Congenital Myasthenic Syndrome: A Systematic Review
Congenital myasthenic syndromes (CMS) are inherited disorders of neuromuscular transmission with few effective treatments. Salbutamol, a β2-adrenergic
- Open Access
- 5 September 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 376
Spinal myxopapillary ependymoma with anaplastic features: A case report and review of the literature
Background: Spinal myxopapillary ependymomas (MPEs) are a rare subtype of ependymomas that typically arise in the conus medullaris, cauda equina, and filum terminale, most commonly affecting adults aged 30–50 years and usually located in the lumbosacral spine. Anaplastic MPEs are an even rarer, more aggressive variant that often present at a younger age than conventional MPEs. Case Description: We report a 20-month-old male who presented with a two-week history of abnormal gait and neck stiffness and was diagnosed with anaplastic MPE. Conclusion: This case adds to the limited pediatric literature on anaplastic MPE and underscores the importance of early recognition, thorough histopathological evaluation, and long-term follow-up.
- 5 September 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 376
Open AccessSpinal myxopapillary ependymoma with anaplastic features: A case report and review of the literature
Background: Spinal myxopapillary ependymomas (MPEs) are a rare subtype of ependymomas that typically arise in the conus medullaris, cauda equina, and filum terminale, most commonly affecting adults aged 30–50 years and usually located in the lumbosacral spine. Anaplastic MPEs are an even rarer, more aggressive variant that often present at a younger age than conventional MPEs. Case Description: We report a 20-month-old male who presented with a two-week history of abnormal gait and neck stiffness and was diagnosed with anaplastic MPE. Conclusion: This case adds to the limited pediatric literature on anaplastic MPE and underscores the importance of early recognition, thorough histopathological evaluation, and long-term follow-up.
- Open Access
- 1 March 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 128 (C) , 111100
Pediatric inguinal-perineal cavernous hemangioma: A rare presentation and surgical outcome
Introduction: Case presentation: Discussion: Conclusion: Highlights:
- 1 March 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 128 (C) , 111100
Open AccessPediatric inguinal-perineal cavernous hemangioma: A rare presentation and surgical outcome
Introduction: Case presentation: Discussion: Conclusion: Highlights:
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1)
Neonatal Brucellosis in an Extremely Preterm Infant: A Fatal Case Report
Background: Brucellosis is a globally significant zoonotic disease, but congenital brucellosis remains exceedingly rare. It is primarily transmitted transplacentally from an infected mother to the fetus, often presenting with nonspecific signs that mimic neonatal sepsis. The condition poses diagnostic and therapeutic challenges, particularly in endemic regions where early identification is crucial to improving neonatal outcomes. Case Presentation: We report the case of a 19‐year‐old gravida 1, para 0 female with a history of treated Brucella infection at 12 weeks of gestation. She experienced preterm premature rupture of membranes (PPROM) at 24 weeks and 2 days and delivered a female infant via spontaneous vaginal delivery. The neonate, weighing 725 g at birth, presented with cyanosis, respiratory distress, and unstable vital signs. Initial workup suggested early onset sepsis, prompting empirical antibiotic therapy. However, on Day 7, blood cultures confirmed the presence of Brucella melitensis and Brucella abortus , establishing the diagnosis of congenital brucellosis. The neonate’s clinical course was complicated by intraventricular hemorrhage, necrotizing enterocolitis, multiple episodes of sepsis, and cardiac arrests. Despite intensive medical management, including antimicrobial therapy with rifampicin and gentamicin, the infant succumbed to multiple organ failure on Day 39 of life. Conclusion: This case highlights the diagnostic challenges of congenital brucellosis and underscores the importance of considering Brucella infection in neonates presenting with unexplained sepsis, especially in endemic regions. Early recognition and targeted therapy are essential to improve neonatal outcomes. Enhanced screening protocols for pregnant women in high‐risk areas, coupled with heightened clinical suspicion in neonates with maternal brucellosis exposure, could facilitate timely diagnosis and treatment.
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1)
Open AccessNeonatal Brucellosis in an Extremely Preterm Infant: A Fatal Case Report
Background: Brucellosis is a globally significant zoonotic disease, but congenital brucellosis remains exceedingly rare. It is primarily transmitted transplacentally from an infected mother to the fetus, often presenting with nonspecific signs that mimic neonatal sepsis. The condition poses diagnostic and therapeutic challenges, particularly in endemic regions where early identification is crucial to improving neonatal outcomes. Case Presentation: We report the case of a 19‐year‐old gravida 1, para 0 female with a history of treated Brucella infection at 12 weeks of gestation. She experienced preterm premature rupture of membranes (PPROM) at 24 weeks and 2 days and delivered a female infant via spontaneous vaginal delivery. The neonate, weighing 725 g at birth, presented with cyanosis, respiratory distress, and unstable vital signs. Initial workup suggested early onset sepsis, prompting empirical antibiotic therapy. However, on Day 7, blood cultures confirmed the presence of Brucella melitensis and Brucella abortus , establishing the diagnosis of congenital brucellosis. The neonate’s clinical course was complicated by intraventricular hemorrhage, necrotizing enterocolitis, multiple episodes of sepsis, and cardiac arrests. Despite intensive medical management, including antimicrobial therapy with rifampicin and gentamicin, the infant succumbed to multiple organ failure on Day 39 of life. Conclusion: This case highlights the diagnostic challenges of congenital brucellosis and underscores the importance of considering Brucella infection in neonates presenting with unexplained sepsis, especially in endemic regions. Early recognition and targeted therapy are essential to improve neonatal outcomes. Enhanced screening protocols for pregnant women in high‐risk areas, coupled with heightened clinical suspicion in neonates with maternal brucellosis exposure, could facilitate timely diagnosis and treatment.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Hemophagocytic Lymphohistiocytosis due to Brucellosis in a Xeroderma Pigmentosum Pediatric Patient: A Case Report and Review of the Literature
We report a pediatric patient with xeroderma pigmentosum (XP) who developed hemophagocytic lymphohistiocytosis (HLH) secondary to Brucella infection—an exceedingly rare occurrence. XP is a rare autosomal recessive genetic disorder characterized by extreme ultraviolet radiation (UVR) sensitivity due to the inability to repair DNA pyrimidine dimers caused by UV exposure. This defect leads to a markedly increased risk of skin cancer and progressive neurological degeneration (Leung, 2022). HLH is a rare, potentially fatal hypersensitivity syndrome characterized by excessive activation and impaired downregulation of T‐lymphocytes and macrophages. This dysregulation results in an overproduction of proinflammatory cytokines, destruction of blood cells, and subsequent tissue and organ damage (Fisman, 2000). While secondary HLH may follow various infections, Brucella‐induced HLH is rare (Wolska, 2006), and to our knowledge, this is the first reported case in a patient with XP.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessHemophagocytic Lymphohistiocytosis due to Brucellosis in a Xeroderma Pigmentosum Pediatric Patient: A Case Report and Review of the Literature
We report a pediatric patient with xeroderma pigmentosum (XP) who developed hemophagocytic lymphohistiocytosis (HLH) secondary to Brucella infection—an exceedingly rare occurrence. XP is a rare autosomal recessive genetic disorder characterized by extreme ultraviolet radiation (UVR) sensitivity due to the inability to repair DNA pyrimidine dimers caused by UV exposure. This defect leads to a markedly increased risk of skin cancer and progressive neurological degeneration (Leung, 2022). HLH is a rare, potentially fatal hypersensitivity syndrome characterized by excessive activation and impaired downregulation of T‐lymphocytes and macrophages. This dysregulation results in an overproduction of proinflammatory cytokines, destruction of blood cells, and subsequent tissue and organ damage (Fisman, 2000). While secondary HLH may follow various infections, Brucella‐induced HLH is rare (Wolska, 2006), and to our knowledge, this is the first reported case in a patient with XP.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Unveiling the Gray: A Rare Case of Gray Platelet Syndrome With Hepatomegaly and Immune Dysregulation in a 14‐Year‐Old
Gray platelet syndrome (GPS) is a rare inherited platelet disorder characterized by the presence of gray platelets on blood smears, resulting from a deficiency of α ‐granules. The thrombocytopenia presents in a spectrum of bleeding tendencies, varying among different patients. We present a case of a 14‐year‐old male presenting with recurrent epistaxis, thrombocytopenia, hepatosplenomegaly, and recurrent infections that had not been diagnosed previously. Whole‐exome gene sequencing revealed a homozygous likely pathogenic splice‐site variant in the NBEAL2 gene, confirming the diagnosis of GPS, which is inherited in an autosomal recessive manner due to biallelic variants in NBEAL2. The patient had atypical hepatomegaly and low lymphocyte and monocyte counts, findings consistent with emerging evidence that GPS affects multiple hematopoietic lineages. It also contributes to immune dysregulation and results in increased susceptibility to autoimmune disorders, highlighting the need for guidelines to screen for autoimmune complications in GPS patients.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessUnveiling the Gray: A Rare Case of Gray Platelet Syndrome With Hepatomegaly and Immune Dysregulation in a 14‐Year‐Old
Gray platelet syndrome (GPS) is a rare inherited platelet disorder characterized by the presence of gray platelets on blood smears, resulting from a deficiency of α ‐granules. The thrombocytopenia presents in a spectrum of bleeding tendencies, varying among different patients. We present a case of a 14‐year‐old male presenting with recurrent epistaxis, thrombocytopenia, hepatosplenomegaly, and recurrent infections that had not been diagnosed previously. Whole‐exome gene sequencing revealed a homozygous likely pathogenic splice‐site variant in the NBEAL2 gene, confirming the diagnosis of GPS, which is inherited in an autosomal recessive manner due to biallelic variants in NBEAL2. The patient had atypical hepatomegaly and low lymphocyte and monocyte counts, findings consistent with emerging evidence that GPS affects multiple hematopoietic lineages. It also contributes to immune dysregulation and results in increased susceptibility to autoimmune disorders, highlighting the need for guidelines to screen for autoimmune complications in GPS patients.